ARGX vs ONC
argenx SE and BeOne Medicines AG, both Healthcare
argenx SE is the larger company at $55B against $28B. Over the past year ARGX returned +56% against +26% for ONC. Ryufin's sector-relative Smart Score puts ONC ahead, 8/10 against 7/10.
| Figure | ARGX | ONC |
|---|---|---|
| Last close | $1047 | $376 |
| Market cap | $55B | $28B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 53.5 | n/a |
| 1-year return | +56% | +26% |
| 5-year return | +239% | +15% |
| Ryufin Smart Scoresector-relative, 1–10 | 7/10 | 8/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
argenx SE
Revenue of $2.5B in H2 2025, net income $877M.
BeOne Medicines AG
Open these two in the interactive comparison to add more names, change the period or read the correlation.